HORMONAL AND METABOLIC ASPECTS OF EATING BEHAVIOR OF YOUNG WOMEN WITH DIFFERENT BODY WEIGHT AND COMPOSITION

Misura K. V., Manska K. G.

CLINICAL AND EXPERIMENTAL MEDICINE

Scentific article

The article presents the data of complex analysis of eating behavior in 130 young women – representatives of the Ukrainian population with different body weight depending on its composition, topography of adipose tissue deposition, melatonin secretion, presence and degree of insulin resistance. There was a direct relationship between the depth of eating disorders and the degree of fat deposition, the severity of insulin resistance; the inverse relationship is between the severity of eating disorders and the average daily urinary excretion of the metabolite melatonin-6-sulfatoxymelatonin, a drop in the relative content of metabolically active tissues. This relationship is the most expressive relative to the restrictive type of eating behavior, which can be considered a feature of young women – representatives of the Ukrainian population. A significant difference between women with overweight from patients with obesity is the normal average score in the group on the answers relative to EB on the restrictive and external type; from women with overweight the presence of EB disorders by emotionogenic type. Young women with moderate abortion, in contrast to those with normal OT, have violations of EB by emotionogenic and external types. Women with severe abortion also have all three types of EB disorders, the severity of which increases with the degree of abortion. The priority results of the work were the determination of regression equations with respect to the above-described correlative relationships in young women-representatives of the Ukrainian population.

obesity, overweight, eating behavior, body composition, melatonin, insulin resistance.

1. Razina AO, Achkasov EE, Runenko SD. Ozhirenie: sovremennyj vzglyad na problemu. Ozhirenie i metabolizm. 2016;13(1):3-8. [in Russian].
2. Schoeller D. The Challenge of Obesity in the WHO European Region and the Strategies for Response. Medicine & Science in Sports & Exercise. 2008;40(3):590. DOI: 10.1249/mss.0b013e318164f33c
3.  James W. The epidemiology of obesity: the size of the problem. J. Intern. Med. 2008;263(4):336-52. DOI: 10.1111/j.1365-2796.2008.01922.x
4. Koromyslov AV, Margazin VA. Rol’ organizovannoj dvigatel’noj aktivnosti v formirovanii pokazatelej fizicheskogo razvitiya studentov za vremya obucheniya v vuze. Yaroslavskij pedagogicheskij vestnik. 2013;1(3):112-7. [in Russian].
5. Volkova GE. Pishchevoe povedenie, emocional’no-lichnostnye osobennosti mediatory energeticheskogo obmena u bol’nyh ozhireniem [avtoreferat]. GOU VPO Perv. Mosk. gos. med. un-t. M.: 2011. 26 s. [in Russian].
6. Azagba S, Sharaf MF. Eating Behavior and Obesity in Canada. Journal of Primary Care & Community Health. 2012;3(1):57-64.
7. McCuen-Wurst C, Ruggieri M, Allison KC. Disordered eating and obesity: associations between binge-eating disorder, night-eating syndrome, and weight-related comorbidities. Ann N Y Acad Sci. 2018 Jan;1411(1):96-105. DOI: 10.1111/nyas.13467. Epub 2017 Oct 16. DOI: 10.1111/ nyas.13467
8.  Moskalenko VF. Konceptual’nі pіdhodi do formuvannya novoу profіlaktichnoу strategіі u sferі ohoroni zdorov’ya. Zdorov’ya Ukrayini. 2009;23(228):48-9. [in Ukrainian].
9. Van Streien T. The Dutch eating behavior questionnaire (DEBQ) for assessment of restraind, emotional and external eating behaviour. Int. J. Eat. Dis. 1986;2:188-204.
10. Giannini, James A, Slaby, Andrew E, editors. The eating disorders. Am. J. New York: Springer. Verlag; 1993. 283 p.
11. Fuentes Pacheco A, Carrillo Balam G, Archibald D. Exploring the relationship between local food environments and obesity in UK, Ireland, Australia and New Zealand: a systematic review protocol. BMJ Open. 2018 Feb 22;8(2):e018701. DOI: 10.1136/bmjopen-2017-018701
12. Metabolic Risk Factors for Chronic Diseases Collaboration (BMI Mediated Effects) of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1,8 million participants. Lancet. 2013;22:970-83. DOI: 10.1016/S0140–6736(13)61836-X
13. Trushkina IV, Filippov GP, Leont’eva IV. Ocenka struktury tela u pacientov s razlichnoj stepen’yu izbytka vesa. Sibirskij med. zhurn. 2010:3- 1(25):38-44. [in Russian].
14. Crane JD, Palanivel R, Mottillo EP. Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis. Nat Med. 2015 Feb;21(2):166-72. DOI: 10.1038/nm.3766. Epub 2014 Dec 8.
15. Vasendin DV. Mediko-biologicheskie effekty melatonina: nekotorye itogi i perspektivy izucheniya. Vestnik rossijskoj voenno-medicinskoj akademii. 2016;3(55):171-8. [in Russian].
16.  Mosolov SN, redaktor. Khronobiologicheskaya gipoteza affektivnykh rasstroystv. M.: Avanport; 2014. 352 s. [in Russian].
17. Nolan LJ, Geliebter A. Night eating is associated with emotional and external eating in college students. Eat Behav. 2012 Aug;13(3):202-6.
18.  Alekseeva NS, Salmina-Hvostova OI, Beloborodova EV. Vzaimosvyaz’ narushenij pishchevogo povedeniya s urovnem melatonina i serotonina pri metabolicheskom sindrome. Sibirskij vestnik psihiatrii i narkologii. 2016;4(93):39-44. [in Russian].
19. Nіkіforova YaV. Vzaуеmozv’yazok harchovoу povedіnki z metabolіchnimi chinnikami riziku. Suchasna gastroenterologіya. 2015;113-21. [in Ukrainian].
20. Levin YaI, Eligulashvili TS, Posohov SI, Kovrov GV, Bashmakov MYu. Farmakoterapiya insomnij: rol’ imovana. V sb.: Rasstrojstva sna (pod red. Aleksandrovskogo YuA, Vejna AM.). SPb.: Medicinskoe informacionnoe agentstvo; 1995. s. 56-61. [in Russian].
21. WHO. Obesity: Preventing and managing the global epidemic: Report of a WHO Consultation. Geneva, 2000. 252 p.
22. Voznesenskaya TG. Tipologiya narusheniy pishchevogo povedeniya i emotsional’no-lichnostnyye rasstroystva pri pervichnom ozhirenii i ikh korrektsiya. V: Ozhireniye; pod red. Dedova II, Mel’nichenko GA. M.: Med. inform. agentstvo; 2004. Glava 9, s. 234-71. [in Russian].
23. World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. WMA, 2004. 32 p.
24. Viktorova LN, Gorodeckij VK. Kolorimetricheskij metod opredeleniya nefermentativno-glikozilirovannogo al’bumina i gemoglobina. Lab. delo. 1990;5:15-8. [in Russian].
25. Zubkov GV, Petrishin VD, Chipirenko VA, Aniskina AA. Metod opredeleniya melatonina (N-acetil-5-metoksitriptamina) v moche. Sbornik nauchnyh trudov Har’kovskogo med. instituta. 1974;109:77-81. [in Russian].
26. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998;21(12):2191-2.
27.  The IDF consensus worldwide definition of the metabolic syndrome. International Diabetes Federation. The Lancet. 2005 January;366:1059-62.
28. Alekseev VV, Karpishchenko AI. Medicinskie laboratornye tekhnologii: rukovodstvo po klinicheskoj laboratornoj diagnostike: v 2 t. Moskva: 2012;1:472. [in Russian].
29. World Medical Association Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. WMA, 2004. 32 p.

«Bulletin of problems biology and medicine» Issue 4 Part 1 (153), 2019 year, 118-126 pages, index UDK 616.056.52:616-036.22-08

10.29254/2077-4214-2019-4-1-153-118-126